Cargando…

Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records

IMPORTANCE: Recent reports on waning of COVID-19 vaccine–induced immunity have led to the approval and rollout of additional doses and booster vaccinations. Individuals at increased risk of SARS-CoV-2 infection are receiving additional vaccine doses in addition to the regimen that was tested in clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niesen, Michiel J. M., Pawlowski, Colin, O’Horo, John C., Challener, Doug W., Silvert, Eli, Donadio, Greg, Lenehan, Patrick J., Virk, Abinash, Swift, Melanie D., Speicher, Leigh L., Gordon, Joel E., Geyer, Holly L., Halamka, John D., Venkatakrishnan, A. J., Soundararajan, Venky, Badley, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011130/ https://www.ncbi.nlm.nih.gov/pubmed/35420661 http://dx.doi.org/10.1001/jamanetworkopen.2022.7038

Ejemplares similares

Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
por: Puranik, Arjun, et al.
Publicado: (2021)

SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes
por: Pawlowski, Colin, et al.
Publicado: (2022)

Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection
por: Puranik, Arjun, et al.
Publicado: (2022)

FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
por: Pawlowski, Colin, et al.
Publicado: (2021)

Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection
por: Niesen, Michiel J M, et al.
Publicado: (2022)

Durability analysis of the highly effective BNT162b2 vaccine against COVID-19
por: Puranik, Arjun, et al.
Publicado: (2022)

Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19
por: Puranik, Arjun, et al.
Publicado: (2022)

Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System
por: Pawlowski, Colin, et al.
Publicado: (2021)

Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance
por: Lenehan, Patrick J., et al.
Publicado: (2021)

Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants
por: Venkatakrishnan, A. J., et al.
Publicado: (2023)

Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19
por: Corchado-Garcia, Juan, et al.
Publicado: (2021)

Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines
por: McMurry, Reid, et al.
Publicado: (2021)

Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
por: Pawlowski, Colin, et al.
Publicado: (2021)

Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
por: Pawlowski, Colin, et al.
Publicado: (2021)

Mapping each pre-existing condition’s association to short-term and long-term COVID-19 complications
por: Venkatakrishnan, A. J., et al.
Publicado: (2021)

Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions
por: Ghosh, Pritha, et al.
Publicado: (2022)

Pre-existing conditions are associated with COVID-19 patients’ hospitalization, despite confirmed clearance of SARS-CoV-2 virus
por: Pawlowski, Colin, et al.
Publicado: (2021)

On the Origins of Omicron’s Unique Spike Gene Insertion
por: Venkatakrishnan, A. J., et al.
Publicado: (2022)

Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest
por: Anand, Praveen, et al.
Publicado: (2022)

Long-term SARS-CoV-2 RNA Shedding and its Temporal Association to IgG Seropositivity
por: Agarwal, Vineet, et al.
Publicado: (2020)

High diversity in Delta variant across countries revealed by genome‐wide analysis of SARS‐CoV‐2 beyond the Spike protein
por: Suratekar, Rohit, et al.
Publicado: (2022)

Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
por: Agarwal, Vineet, et al.
Publicado: (2020)

Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC)
por: Pawlowski, Colin, et al.
Publicado: (2020)

Vaccination Safety: Don’t Toss the Champagne With the Cork
por: Shah, Aditya, et al.
Publicado: (2021)

Quantifying the immunological distinctiveness of emerging SARS-CoV-2 variants in the context of prior regional herd exposure
por: Niesen, Michiel J M, et al.
Publicado: (2022)

Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients
por: Awasthi, Samir, et al.
Publicado: (2021)

Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis
por: Wagner, Tyler, et al.
Publicado: (2020)

Benchmarking evolutionary tinkering underlying human–viral molecular mimicry shows multiple host pulmonary–arterial peptides mimicked by SARS-CoV-2
por: Venkatakrishnan, A. J., et al.
Publicado: (2020)

In reply—Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
por: O’Horo, John C., et al.
Publicado: (2021)

Infectious disease physician characteristics and prescription of meropenem in the hospital
por: Challener, Douglas, et al.
Publicado: (2023)

Counties with Lower Insurance Coverage and Housing Problems Are Associated with Both Slower Vaccine Rollout and Higher COVID-19 Incidence
por: Donadio, Gregory, et al.
Publicado: (2021)

Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19
por: Razonable, Raymund R., et al.
Publicado: (2021)

Healthcare disparities among anticoagulation therapies for severe COVID‐19 patients in the multi‐site VIRUS registry
por: Kirkup, Christian, et al.
Publicado: (2021)

1340. The Effect of Continuous Renal Replacement Therapy on Body Temperature in Patients with and without Infection
por: Challener, Douglas W, et al.
Publicado: (2019)

A Blueprint to Control the SARS-CoV-2 Pandemic
por: O’Horo, John C., et al.
Publicado: (2021)

Healthcare personnel absenteeism, presenteeism, and staffing challenges during epidemics
por: Challener, Douglas W., et al.
Publicado: (2020)

Association Between Chronic Statin Use and 30-Day Mortality in Hospitalized Patients With COVID-19
por: Yetmar, Zachary A., et al.
Publicado: (2021)

Continuous genomic diversification of long polynucleotide fragments drives the emergence of new SARS-CoV-2 variants of concern
por: Murugadoss, Karthik, et al.
Publicado: (2022)

1243. Comparative Analysis of Antimicrobial-related Adverse Events in the Outpatient Treatment of Staphylococcal Infections
por: Smith, Bradley, et al.
Publicado: (2018)

Analytics and Prediction Modeling During the COVID-19 Pandemic
por: Challener, Douglas W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q50pvq7vpns550rt4604pt7n67